We are live on ! Find out more
CFB

Cullen/Frost Bankers Portfolio holdings

AUM $10.1B
1-Year Est. Return 29.18%
This Fund
S&P 500
This Quarter Est. Return
+9.82%
1 Year Est. Return
+29.18%
3 Year Est. Return
+91.06%
5 Year Est. Return
+115.39%
10 Year Est. Return
+478.9%
AUM
$4.02B
AUM Growth
+$223M
Cap. Flow
-$95.4M
Cap. Flow %
-2.38%
Top 10 Hldgs %
27.72%
Holding
1,328
New
200
Increased
297
Reduced
377
Closed
136

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$17.9M
2
SFNC icon
Simmons First National
SFNC
+$13.6M
3
AMAT icon
Applied Materials
AMAT
+$13.5M
4
XLNX
Xilinx Inc
XLNX
+$11.9M
5
AAPL icon
Apple
AAPL
+$8.08M

Sector Composition

Rank Sector Weight
1 Technology 21.14%
2 Healthcare 12.66%
3 Financials 12.61%
4 Consumer Discretionary 12.09%
5 Communication Services 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAJ
1051
DELISTED
Canon, Inc.
CAJ
$2K ﹤0.01%
118
GWPH
1052
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2K ﹤0.01%
25
VAR
1053
DELISTED
Varian Medical Systems, Inc.
VAR
$2K ﹤0.01%
+12
New +$1.89K
ROSE
1054
DELISTED
Rosehill Resources Inc. Class A
ROSE
$2K ﹤0.01%
47,768
AIZ icon
1055
Assurant
AIZ
$13.9B
$1K ﹤0.01%
+10
New +$1.15K
ALV icon
1056
Autoliv
ALV
$8.84B
$1K ﹤0.01%
+11
New +$781
AMCX icon
1057
AMC Global Media
AMCX
$497M
$1K ﹤0.01%
43
+17
+65% +$408
BCS icon
1058
Barclays
BCS
$94.6B
$1K ﹤0.01%
+201
New +$1.11K
BMO icon
1059
Bank of Montreal
BMO
$129B
$1K ﹤0.01%
12
BMRN icon
1060
BioMarin Pharmaceuticals
BMRN
$13.3B
$1K ﹤0.01%
+18
New +$1.82K
BPT
1061
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$1K ﹤0.01%
895
BURL icon
1062
Burlington
BURL
$22.2B
$1K ﹤0.01%
+3
New +$584
CCEP icon
1063
Coca-Cola Europacific Partners
CCEP
$47.3B
$1K ﹤0.01%
37
-1,353
-97% -$55.4K
CDW icon
1064
CDW
CDW
$17.3B
$1K ﹤0.01%
10
-390
-98% -$44.6K
CM icon
1065
Canadian Imperial Bank of Commerce
CM
$111B
$1K ﹤0.01%
18
-48
-73% -$1.76K
CNNE icon
1066
Cannae Holdings
CNNE
$674M
$1K ﹤0.01%
+30
New +$1.14K
COO icon
1067
Cooper Companies
COO
$14.9B
$1K ﹤0.01%
+12
New +$921
CRH icon
1068
CRH
CRH
$65.7B
$1K ﹤0.01%
+17
New +$640
CRNT icon
1069
Ceragon Networks
CRNT
$201M
$1K ﹤0.01%
+445
New +$1.07K
CRSP icon
1070
CRISPR Therapeutics
CRSP
$5.21B
$1K ﹤0.01%
+10
New +$887
CVNA icon
1071
Carvana
CVNA
$82.1B
$1K ﹤0.01%
+30
New +$1.06K
DGX icon
1072
Quest Diagnostics
DGX
$26.1B
$1K ﹤0.01%
+11
New +$1.3K
DXCM icon
1073
DexCom
DXCM
$34.2B
$1K ﹤0.01%
8
+4
+100% +$418
EIX icon
1074
Edison International
EIX
$26.6B
$1K ﹤0.01%
22
-329
-94% -$17.5K
ELS icon
1075
Equity Lifestyle Properties
ELS
$12.6B
$1K ﹤0.01%
22
-678
-97% -$43.9K

Similar funds

Cullen/Frost Bankers's Q3 2020 Portfolio in Review

As of Q3 2020, Cullen/Frost Bankers held 1,328 positions worth $4.02B, up 5.9% from $3.79B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Cullen/Frost Bankers's Q3 2020 filing shows 200 new, 297 increased, 377 reduced and 136 closed positions. Its largest new stake was INPHI CORPORATION: 96,001 shares worth $10.8M. The largest sale was AbbVie, an estimated $17.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Cullen/Frost Bankers's largest Q3 2020 buy was INPHI CORPORATION: 96,001 shares worth $10.8M.
  • Cullen/Frost Bankers added most to Qualcomm in Q3 2020, an estimated $13.8M increase.
  • Cullen/Frost Bankers's biggest Q3 2020 reduction was AbbVie, cutting an estimated $17.9M.
  • Cullen/Frost Bankers fully exited Simmons First National in Q3 2020, selling an estimated $13.6M.
  • Cullen/Frost Bankers's ten largest holdings make up 28% of its $4.02B portfolio in Q3 2020.
  • Cullen/Frost Bankers opened 200 new positions and closed 136 in Q3 2020.
  • Cullen/Frost Bankers's portfolio value rose 5.9% quarter-over-quarter to $4.02B.

Based on Cullen/Frost Bankers's 13F filing for Q3 2020, filed 5 Nov 2020.